Esthesioneuroblastoma, a rare type of cancer, arises from the olfactory epithelium in the nasal cavity. Research on esthesioneuroblastoma focuses on understanding its genetic and molecular characteristics to develop targeted therapies. Scientists are exploring novel treatment approaches such as immunotherapy and precision medicine to improve patient outcomes. Additionally, advancements in imaging techniques aid in early detection and accurate staging of the disease, enabling timely intervention. Collaborative efforts among oncologists, geneticists, and bioinformaticians are essential to unravel the complexities of esthesioneuroblastoma and devise personalized treatment strategies. Despite its rarity, ongoing research endeavors strive to enhance our understanding of this malignancy and pave the way for more effective therapies, offering hope to individuals affected by esthesioneuroblastoma.



Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States
Title : Graphene quantum dots: A new frontier for photodynamic therapy
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil